Blis forecasts doubling in full-year sales, small pretax surplus, after first-half loss narrows

Blis forecasts doubling in full-year sales, small pretax surplus, after first-half loss narrows
Jonathan Underhill
By Jonathan Underhill Nov. 20 (BusinessDesk) - Blis Technologies, the probiotics manufacturer that has replaced its chief executive after nine years, expects to double annual sales and achieve a small pretax surplus after narrowing its first-half loss. The loss was $405,000 in the six months ended Sept. 30, from a loss of $808,000 a year earlier, the Dunedin-based company said in a statement. Sales rose to $2.7 million from $1.1 million. Blis, which was set up to commercialise probiotic bacteria for use in consumer products, first list...